Büller HR - Search Results

1

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.

van den Belt AG, Bossuyt PM, Prins MH, Gallus AS, Büller HR. van den Belt AG, et al. Among authors: buller hr. Thromb Haemost. 1998 Feb;79(2):259-63. Thromb Haemost. 1998. PMID: 9493572

2

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.

Botticelli Investigators, Writing Committe; Buller H, Deitchman D, Prins M, Segers A. Botticelli Investigators, Writing Committe, et al. J Thromb Haemost. 2008 Aug;6(8):1313-8. doi: 10.1111/j.1538-7836.2008.03054.x. Epub 2008 Jun 6. J Thromb Haemost. 2008. PMID: 18541000 Free article. Clinical Trial.

3

Treatment of venous thromboembolism.

ten Cate JW, Koopman MM, Prins MH, Büller HR. ten Cate JW, et al. Among authors: buller hr. Thromb Haemost. 1995 Jul;74(1):197-203. Thromb Haemost. 1995. PMID: 8578457

4

Bleeding classification in clinical trials: observer variability and clinical relevance.

Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Büller HR. Graafsma YP, et al. Among authors: buller hr. Thromb Haemost. 1997 Oct;78(4):1189-92. Thromb Haemost. 1997. PMID: 9364983

5

Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?

Turkstra F, Karemaker R, Kuijer PM, Prins MH, Büller HR. Turkstra F, et al. Among authors: buller hr. Thromb Haemost. 1999 Mar;81(3):345-8. Thromb Haemost. 1999. PMID: 10102457

6

Safety of low-molecular-weight heparin in pregnancy: a systematic review.

Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z, Turi S, Mac Gillavry MR, Hamulyák K, Theunissen IM, Hunt BJ, Büller HR. Sanson BJ, et al. Among authors: buller hr. Thromb Haemost. 1999 May;81(5):668-72. Thromb Haemost. 1999. PMID: 10365733 Review.

7

Long-term treatment of venous thromboembolic disease.

Prins MH, Hutten BA, Koopman MM, Büller HR. Prins MH, et al. Among authors: buller hr. Thromb Haemost. 1999 Aug;82(2):892-8. Thromb Haemost. 1999. PMID: 10605799 Review. No abstract available.

8

Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.

Hettiarachchi RJ, Smorenburg SM, Ginsberg J, Levine M, Prins MH, Büller HR. Hettiarachchi RJ, et al. Among authors: buller hr. Thromb Haemost. 1999 Aug;82(2):947-52. Thromb Haemost. 1999. PMID: 10605808 No abstract available.

9

High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.

Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Büller HR. Kraaijenhagen RA, et al. Among authors: buller hr. Thromb Haemost. 2000 Jan;83(1):5-9. Thromb Haemost. 2000. PMID: 10669145

10

Low-molecular weight heparins in venous and arterial thrombotic disease.

Bijsterveld NR, Hettiarachchi R, Peters R, Prins MH, Levi M, Büller HR. Bijsterveld NR, et al. Among authors: buller hr. Thromb Haemost. 1999 Sep;82 Suppl 1:139-47. Thromb Haemost. 1999. PMID: 10695506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters